67
Growth Score in past quarter
pts
Heat Score 67 in past quarter
9 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
486361
Pulmovant develops investigational therapies for respiratory diseases and shares pipeline and clinical study information.
About the Company
Pulmovant researches and develops treatments aimed at respiratory disease. The portfolio centers on investigational medicines designed to improve lung function, reduce symptoms, and address underlying disease drivers. Activities span target discovery, preclinical pharmacology, formulation, and early-stage clinical trials. Public materials outline
pipeline programs, scientific publications, and opportunities for clinical trial participation. Partnerships with academic and clinical investigators support translational studies and data generation. The website provides contacts and resources for patients, caregivers, and professionals interested in study enrollment and research updates.